Exercise and XXXX .

@entity1 @entity6 @entity28 @entity164 @entity1720 @entity413
Diet and exercise form the foundation of a healthy lifestyle. These are especially important for @entity1 living with @entity6 , as they are the most practical non-pharmacological means by which @entity1 may significantly improve their blood @entity413 levels. Exercise @entity1720 (both short and long term), lowers blood sugar levels, reduces body fat and improves cardiovascular (CV) function. Because of this, exercise offers enormous benefit to @entity1 with @entity6 . Blood @entity413 levels can significantly drop during and after physical activities, due to the increased utilisation of @entity413 as a fuel during exercise and the up-regulation of @entity413 transport into working muscles. Therefore, @entity1 (especially those with @entity164 1 @entity6 ) must account for the effects of exercise and adjust their medications and nutrition accordingly. Improvements in real-time continuous @entity413 monitoring and optimisation of basal insulin dosing may offer significant benefit to preventing hypoglycaemia in @entity1 with @entity164 1 @entity6 who regularly exercise. Diverse exercise programmes and devices can also assist @entity1 in monitoring their activities as well as motivating them to achieve their exercise goals. For @entity1 with @entity164 1 @entity6 , questions such as how much, how long, how strenuous and what kind of exercise must be addressed in order for healthcare professionals to offer maximum benefit to their @entity1 . Additionally, since @entity1 with @entity164 2 @entity6 often have other significant co-morbidities such as @entity28 and CV disease, care providers must evaluate each @entity1 's risk factors before designing an exercise programme. Several publications in the last year have addressed these issues and may serve as a valuable resource to provide safe and effective recommendations to @entity1 and their healthcare providers. To be included in the Exercise and @entity6 chapter for the 2010 YEARBOOK, we reviewed leading peer-reviewed manuscripts that were published in the period July 2009 to June 2010. PubMed was used in the initial screening of articles.
